BK

Brett Kaplan

Chief Operating Officer

Eliem Therapeutics


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Eliem Therapeutics
Industry
research
Employees
28.0
Seniority
C suite

Technologies

Mimecast Outlook Microsoft Office 365 Adobe Marketing Cloud WordPress.org Google Tag Manager reCAPTCHA Mobile Friendly

Keywords

biotech clinical development immunology biotechnology: pharmaceutical preparations health care biotechnology research clinical-stage biotechnology therapeutics immune-mediated diseases drug development monoclonal antibodies anti-cd19 b-cell mediated diseases pipeline anti-april iga nephropathy investor relations clinical trials pre-clinical phase 1 phase 2 phase 3 drug candidates biopharma pharmaceutical development patient centric research & development healthcare investor conferences biotech leadership supply chain operations regulatory affairs clinical operations cmc therapeutic innovations disease management clinical advisors affinity maturation cellular therapies monoclonal antibody therapies patient quality of life biotech partnerships clinical studies disease indication patient advocacy corporate governance pipeline expansion biotech investments investor engagement strategic development therapeutic areas clinical research pharmaceutical pipeline research collaborations biotech innovation health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans